Our findings in renal clear cell cancer contradict those of earlier studies17, which showed that HS6ST2 is a potential prognostic biomarker and that inhibition of HS6ST2 causes decreased migration and invasion of RCC cells18. This evidence concerns the gene HS6ST2 and renal cell carcinoma.